JUDITH KING: Open Payments
NPI 1467437947 · BROCKTON, MA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,880 in 83 payments from 19 companies in 2025. Trend: 2023 $1,155 · 2024 $2,475 · 2025 $1,880
Food & beverage: $1,880
| Company | Payments | Amount |
|---|---|---|
| PFIZER INC. | 13 | $263 |
| E.R. Squibb & Sons, L.L.C. | 10 | $230 |
| Novartis Pharmaceuticals Corporation | 16 | $209 |
| GENZYME CORPORATION | 1 | $170 |
| Alnylam Pharmaceuticals Inc. | 6 | $167 |
| Novo Nordisk Inc | 5 | $142 |
| Amgen Inc. | 6 | $131 |
| Bayer Healthcare Pharmaceuticals Inc. | 4 | $100 |
| BridgeBio Pharma, Inc. | 4 | $84 |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | 5 | $75 |
Products named: LEQVIO, ELIQUIS, CAMZYOS, VYNDAQEL, REPATHA, Wegovy, Kerendia, ONPATTRO.
Industry payments across MA — which companies pay providers there.
